Emorfia Gavrilidis

Level 4 607 St Kilda Rd, 
Melbourne, VIC, AU 
Clinical Trials:Currently Recruiting for 1 Trial
Level 4 607 St Kilda Rd, 
Melbourne, VIC, AU 

Overview

Emorfia Gavrilidis practices practicing medicine in Melbourne, Australia.

Their clinical expertise encompasses Menopause, Schizophrenia, Premenstrual Dysphoric Disorder, Premenstrual Syndrome, and Hormone Replacement Therapy (HRT).

They are actively involved in clinical research, co-authoring 23 peer reviewed articles and participating in 2 clinical trials.

Locations

Level 4 607 St Kilda Rd, Melbourne, VIC 3004, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomised Double-blind Placebo Controlled Investigation of the Efficacy of a Novel Drug as an Adjunct in Patients With Borderline Personality Disorder
A Randomised Double-blind Placebo Controlled Investigation of the Efficacy of a Novel Drug as an Adjunct in Patients With Borderline Personality Disorder
Enrollment Status: Recruiting
Publish Date: August 15, 2025
Intervention Type: Other, Drug
Study Drug: N-Methyl-D-Aspartate (NMDA) Receptor Antagonist
Study Phase: Phase 2
Selective Estrogen Receptor Modulators (SERMs) - A Potential New Treatment for Women of Child-bearing Age With Psychotic Symptoms of Schizophrenia
Selective Estrogen Receptor Modulators (SERMs) - A Potential New Treatment for Women of Child-bearing Age With Psychotic Symptoms of Schizophrenia
Enrollment Status: Completed
Publish Date: January 09, 2020
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

23 Total Publications

Bazedoxifene plus conjugated estrogen to treat menopausal depression-A pilot study.
Bazedoxifene plus conjugated estrogen to treat menopausal depression-A pilot study.
Journal: The Journal of pharmacology and experimental therapeutics
Published: August 28, 2024

Frequently Asked Questions about Emorfia Gavrilidis

Is Emorfia Gavrilidis a top-rated expert for Menopause?

MediFind is an objective health platform that identifies experts based on real-world data. Emorfia Gavrilidis is classified as an Experienced expert for Menopause, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Emorfia Gavrilidis participate in research or clinical trials?

Yes. Emorfia Gavrilidis has published 23 articles and abstracts on conditions like Menopause. You can view a list of Emorfia Gavrilidis's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Gavrilidis's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile